NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.47 -0.01 (-0.01%) GOLD FUTURES
2,321.20 -10.00 (-0.43%) DOW
38,907.31 +55.04 (+0.14%) Bitcoin GBP
50,428.82 -23.15 (-0.05%)
Amgen Inc. (AMG.DE)
| Previous close | 277.20 |
| Open | 277.85 |
| Bid | 280.15 x 20000 |
| Ask | 280.45 x 9000 |
| Day's range | 277.85 - 280.50 |
| 52-week range | 196.60 - 306.00 |
| Volume | |
| Avg. volume | 618 |
| Market cap | 151.125B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 43.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 8.29 (2.99%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
- Insider Monkey
15 Best S&P 500 Dividend Stocks To Buy Now
In this article, we discuss 15 best S&P 500 dividend stocks to buy now. You can skip our detailed analysis of dividend stocks in the S&P 500 and their past performance, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy Now. It’s been a dynamic first quarter for the stock market. […]
- Zacks
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- Bloomberg
Investors Pile Into Amgen in Search of Next Obesity Drug Payout
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeJudge Threatens Trump With Jail Over Gag Order ViolationsTreasury Rally Risks Running Into a $125 Billion Brick WallBuffett Praises Apple After Trimming It, Drops Paramount StakeThe shares s
